FDA Approval Decisions Report
December, 2008
| Date: | Dec 01, 2008 |
|---|---|
| Format: | |
| Price: | $125.00 |
Abstract
The Revere FDA Approval Decision Report provides one of the most comprehensive and accurate event calendars for PDUFA dates (Prescription Drug User Fee Act) - expected FDA approval dates for NDA/BLA filed drugs. In particular, this report identifies Biotech/Pharmaceutical companies with expected FDA approvals in the next 3 months and reviews all FDA approval decisions in the current month. Furthermore, the report also analyzes each drug candidate's likelihood of approval and competitive landscape using 3 criteria derived from Revere's patented classification system: (1) Utilization of a mechanism of action previously approved by the FDA, (2) Facing two or fewer alternative drugs with the same mechanism of action for the same indication, and (3) Would be the first or second FDA approved drug for the company. Original, unbiased, insightful and actionable, the Revere FDA Approval Decision Report is an indispensable tool for successful Biotech/Pharmaceutical investing.
Companies Mentioned in the Report
- Novartis AG (ADR) (NVS) - Overview - Reports
- Medicis Pharmaceutical Corporation (MRX) - Overview - Reports
- Medarex inc. (?214788) - Overview - Reports
- Eli Lilly & Co. (LLY) - Overview - Reports
- Ligand Pharmaceuticals Inc. (LGND) - Overview - Reports
- K-V Pharmaceutical Company (KV/A) - Overview - Reports
- King Pharmaceuticals, Inc. (KG) - Overview - Reports
- Johnson & Johnson (JNJ) - Overview - Reports
- Hologic, Inc. (HOLX) - Overview - Reports
- Hemispherx BioPharma, Inc (HEB) - Overview - Reports
- GTC Biotherapeutics, Inc. (GTCB) - Overview - Reports
- Genta Incorporated (GETA) - Overview - Reports
- Genzyme Corporation (GENZ) - Overview - Reports
- Novadel Pharma Inc (NVDL) - Overview - Reports
- Bristol Myers Squibb Co. (BMY) - Overview - Reports
- AMAG Pharmaceuticals, Inc. (AMAG) - Overview - Reports
- Amylin Pharmaceuticals, Inc. (AMLN) - Overview - Reports
- Alkermes, Inc. (ALKS) - Overview - Reports
- Alpharma Inc. (?200936) - Overview - Reports
- Abbott Laboratories (ABT) - Overview - Reports
- Pfizer Inc. (PFE) - Overview - Reports
- Pharmaceutical Product Development, Inc. (PPDI) - Overview - Reports
- Schering-Plough Corp (?221433) - Overview - Reports
- Watson Pharmaceuticals, Inc. (WPI) - Overview - Reports
- Pain Therapeutics, Inc. (PTIE) - Overview - Reports
- AstraZeneca plc (ADR) (AZN) - Overview - Reports
- Acusphere, Inc. (ACUS) - Overview - Reports
- Takeda Pharmaceutical Co Ltd (TKPHF) - Overview - Reports
- DURECT Corporation (DRRX) - Overview - Reports
- Salix Pharmaceuticals, Ltd. (SLXP) - Overview - Reports
- Santarus, Inc. (SNTS) - Overview - Reports
- Bayer AG (ADR) (BAYRY) - Overview - Reports
- Labopharm Inc. (DDSS) - Overview - Reports
- Anesiva, Inc. (ANSVQ) - Overview - Reports
- Accentia Biopharmaceuticals, Inc (ABPIQ) - Overview - Reports
- Somaxon Pharmaceuticals, Inc. (SOMX) - Overview - Reports
- EPIX Pharmaceuticals, Inc. (EPIX) - Overview - Reports
- Targanta Therapeutics Corporation (?492045) - Overview - Reports
More Information:
Learn more about FDA Approval Decisions Report.